Associations between brain morphology and outcome in schizophrenia in a general population sample

European Psychiatry

Volumn 29, Issue 7, 2014, Pages 456-462

  Jaaskelainen E ^a,b   Juola, P ^a   Kurtti, J ^a   Haapea, M ^a,b   Kyllonen M ^a   Miettunen, J ^a,b   Tanskanen, P ^b   Murray, G K ^c   Huhtaniska, S ^a   Barnes, A ^c,d   Veijola, J ^a,b   Isohanni, M ^a,b  

^a UNIVERSITY OF OULU   (Finland)

^b OULU UNIVERSITY HOSPITAL   (Finland)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

Brain; MRI; Outcome; Prognosis; Psychosis; Schizophrenia

Indexed keywords

NEUROLEPTIC AGENT;

ADULT; ARTICLE; BRAIN SIZE; CEREBROSPINAL FLUID; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; DISABILITY; DISEASE ASSOCIATION; DISEASE DURATION; DRUG USE; FEMALE; FINLAND; FOLLOW UP; FRONTAL LOBE; GRAY MATTER; HOSPITALIZATION; HUMAN; LIMBIC CORTEX; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; NEUROANATOMY; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PATHOLOGICAL ANATOMY; PRIORITY JOURNAL; REMISSION; SCHIZOPHRENIA; WHITE MATTER; BRAIN; DISABLED PERSON; EDUCATIONAL STATUS; EMPLOYMENT; ORGAN SIZE; PATHOLOGY; PATHOPHYSIOLOGY; PENSION; PSYCHOLOGY;

ADULT; ANTIPSYCHOTIC AGENTS; BRAIN; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DISABLED PERSONS; EDUCATIONAL STATUS; EMPLOYMENT; FEMALE; FINLAND; FRONTAL LOBE; GRAY MATTER; HUMANS; LIMBIC LOBE; MAGNETIC RESONANCE IMAGING; MALE; ORGAN SIZE; PENSIONS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; WHITE MATTER;

EID: 84921521359     PISSN: 09249338     EISSN: 17783585     Source Type: Journal    
DOI: 10.1016/j.eurpsy.2013.10.006     Document Type: Article

References (49)

1. Andreasen N.C., Carpenter W.T., Kane J.M., Lasser R.A., Marder S.R., Weinberger D.R. Remission in schizophrenia: proposed criteria and rationale for consensus. Am J Psychiatry 2005, 162(3):441-449.
2. Andreasen N.C., Nopoulos P., Magnotta V., Pierson R., Ziebell S., Ho B.C. Progressive brain change in schizophrenia: a prospective longitudinal study of first-episode schizophrenia. Biol Psychiatry 2011, 70:672-679.
3. Bodnar M., Malla A.K., Czechowska Y., Benoit A., Fathalli F., Joober R., et al. Neural markers of remission in first-episode schizophrenia: a volumetric neuroimaging study of the hippocampus and amygdala. Schizophr Res 2010, 122(1-3):72-80.
4. Brammer M.J., Bullmore E.T., Simmons A., Williams S.C., Grasby P.M., Howard R.J., et al. Generic brain activation mapping in functional magnetic resonance imaging: a nonparametric approach. Magn Reson Imaging 1997, 15(7):763-770.
5. Brickman A.M., Buchsbaum M.S., Shihabuddin L., Byne W., Newmark R.E., Brand J., et al. Thalamus size and outcome in schizophrenia. Schizophr Res 2004, 71(2-3):473-484.
6. Buchsbaum M.S., Shihabuddin L., Brickman A.M., Miozzo R., Prikryl R., Shaw R., et al. Caudate and putamen volumes in good and poor outcome patients with schizophrenia. Schizophr Res 2003, 64(1):53-62.
7. García-Martí G., Aguilar E.J., Lull J.J., Martí-Bonmatí L., Escartí M.J., Manjón J.V., et al. Schizophrenia with auditory hallucinations: A voxel-based morphometry study. Prog Neuropsychopharmacol Biol Psychiatry 2008, 32(1):72-80.
8. Ha T.H., Youn T., Ha K.S., Rho K.S., Lee J.M., Kim I.Y., et al. Gray matter abnormalities in paranoid schizophrenia and their clinical correlations. Psychiatry Res Neuroimaging 2004, 132(3):251-260.
9. Haapea M., Miettunen J., Veijola J., Lauronen E., Tanskanen P., Isohanni M. Non-participation may bias the results of a psychiatric survey: an analysis from the survey including magnetic resonance imaging within the Northern Finland 1966 Birth Cohort. Soc Psychiatry Psychiatr Epidemiol 2007, 42(5):403-409.
10. Ho B.C., Andreasen N.C., Nopoulos P., Arndt S., Magnotta V., Flaum M. Progressive structural brain abnormalities and their relationship to clinical outcome. A longitudinal magnetic resonance imaging study early in schizophrenia. Arch Gen Psychiatry 2003, 60:585-594.
11. Ho B.C., Andreasen N.C., Ziebell S., Pierson R., Magnotta V. Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia. Arch Gen Psychiatry 2011, 68(2):128-137.
12. Hulshoff Pol H.E., Schnack H.G., Mandl R.C.W., Cahn W., Collins D.L., Evans A.C., et al. Focal white matter density changes in schizophrenia: reduced inter-hemispheric connectivity. Neuroimage 2004, 21(1):27-35.
13. Isohanni M., Makikyro T., Moring J., Rasanen P., Hakko H., Partanen U., et al. A comparison of clinical and research DSM-III-R diagnoses of schizophrenia in a Finnish national birth cohort. Clinical and research diagnoses of schizophrenia. Soc Psychiatry Psychiatr Epidemiol 1997, 32(5):303-308.
14. Jenkinson M., Smith S. A global optimisation method for robust affine registration of brain images. Med Image Anal 2001, 5(2):143-156.
15. Kasparek T., Prikryl R., Schwarz D., Kucerova H., Marecek R., Mikl M., et al. Grey matter morphology and the level of functioning in one-year follow-up of first-episode schizophrenia patients. Prog Neuropsychopharmacol Biol Psychiatry 2009, 33(8):1438-1446.
16. Kay S.R., Opler L.A., Fiszbein A. Positive and Negative Syndrome Scale (PANSS). Handbook of Psychiatric Measures 2000, American Psychiatric Association, Washington. A.J. Rush (Ed.).
17. Lauronen E., Miettunen J., Veijola J., Karhu M., Jones P.B., Isohanni M. Outcome and its predictors in schizophrenia within the Northern Finland 1966 Birth Cohort. Eur Psychiatry 2007, 22(2):129-136.
18. Lawrie S.M., McIntosh A.M., Hall J., Owens D.G., Johnstone E.C. Brain structure and function changes during the development of schizophrenia: the evidence from studies of subjects at increased genetic risk. Schizophr Bull 2008, 34(2):330-340.
19. Lui S., Deng W., Huang X., Jiang L., Ma X., Chen H., et al. Association of cerebral deficits with clinical symptoms in antipsychotic-naive first-episode schizophrenia: an optimized voxel-based morphometry and resting state functional connectivity study. Am J Psychiatry 2009, 166(2):196-205.
20. Miettunen J., Lauronen E., Veijola J., Koponen H., Saarento O., Taanila A., et al. Socio-demographic and clinical predictors of occupational status in schizophrenic psychoses-follow-up within the Northern Finland 1966 Birth Cohort. Psychiatry Res 2007, 150(3):217-225.
21. Miettunen J., Suvisaari J., Haukka J., Isohanni M. Use of register data for psychiatric epidemiology in the Nordic countries. Textbook in Psychiatric Epidemiology 2011, 117-131. Wiley-Blackwell. 3rd ed. M. Tsuang, M. Tohen, P. Jones (Eds.).
22. Milev P., Ho B.C., Arndt S., Nopoulos P., Andreasen N.C. Initial magnetic resonance imaging volumetric brain measurements and outcome in schizophrenia: a prospective longitudinal study with 5-year follow-up. Biol Psychiatry 2003, 54(6):608-615.
23. Mitelman S.A., Shihabuddin L., Brickman A.M., Hazlett E.A., Buchsbaum M.S. MRI assessment of grey and white matter distribution in Brodmann's areas of the cortex in patients with schizophrenia with good and poor outcomes. Am J Psychiatry 2003, 160(12):2154-2168.
24. Mitelman S.A., Shihabuddin L., Brickman A.M., Hazlett E.A., Buchsbaum M.S. Volume of the cingulate and outcome in schizophrenia. Schizophr Res 2005, 72(2-3):91-108.
25. Mitelman S.A., Brickman A.M., Shihabuddin L., Newmark R.E., Hazlett E.A., Haznedar M.M., et al. A comprehensive assessment of grey and white matter volumes and their relationship to outcome and severity in schizophrenia. Neuroimage 2007, 37(2):449-462.
26. Moilanen K., Veijola J., Laksy K., Makikyro T., Miettunen J., Kantojarvi L., et al. Reasons for the diagnostic discordance between clinicians and researchers in schizophrenia in the Northern Finland 1966 Birth Cohort. Soc Psychiatry Psychiatr Epidemiol 2003, 38(6):305-310.
27. Molina V., Hernandez J.A., Sanz J., Paniagua J.C., Hernandez A.I., Martin C., et al. Subcortical and cortical grey matter differences between Kraepelinian and non-Kraepelinian schizophrenia patients identified using voxel-based morphometry. Psychiatry Res 2010, 184(1):16-22.
28. Navari S., Dazzan P. Do antipsychotic drugs affect brain structure? A systematic and critical review of MRI findings. Psychol Med 2009, 39(11):1763-1777.
29. Paillère-Martinot M., Caclin A., Artiges E., Poline J.B., Joliot M., Mallet L., et al. Cerebral grey and white matter reductions and clinical correlates in patients with early onset schizophrenia. Schizophr Res 2001, 50(1-2):19-26.
30. Penttila M., Jaaskelainen E., Haapea M., Tanskanen P., Veijola J., Ridler K., et al. Association between duration of untreated psychosis and brain morphology in schizophrenia within the Northern Finland 1966 Birth Cohort. Schizophr Res 2010, 123(2-3):145-152.
31. Pressler M., Nopoulos P., Ho B.C., Andreasen N.C. Insular cortex abnormalities in schizophrenia: Relationship to symptoms and typical neuroleptic exposure. Biol Psychiatry 2005, 57(4):394-398.
32. Ridler K., Veijola J.M., Tanskanen P., Miettunen J., Chitnis X., Suckling J., et al. Fronto-cerebellar systems are associated with infant motor and adult executive functions in healthy adults but not in schizophrenia. Proc Natl Acad Sci U S A 2006, 103(42):15651-15656.
33. Rossi A., Bustini M., Prosperini P., Marinangeli M.G., Splendiani A., Daneluzzo E., et al. Neuromorphological abnormalities in schizophrenic patients with good and poor outcome. Acta Psychiatr Scand 2000, 101(2):161-166.
34. Sayo A., Jennings R.G., Van Horn J.D. Study factors influencing ventricular enlargement in schizophrenia: A 20 year follow-up meta-analysis. Neuroimage 2012, 59(1):154-167.
35. Schmahmann J.D., Doyon J., McDonald D., Holmes C., Lavoie K., Hurwitz A.S., et al. Three-dimensional MRI atlas of the human cerebellum in proportional stereotaxic space. Neuroimage 1999, 10(3 Pt 1):233-260.
36. Shenton M.E., Dickey C.C., Frumin M., McCarley R.W. A review of MRI findings in schizophrenia. Schizophr Res 2001, 49:1-52.
37. Shepherd A.M., Laurens K.R., Matheson S.L., Carr V.J., Green M.J. Systematic meta-review and quality assessment of the structural brain alterations in schizophrenia. Neurosci Biobehav Rev 2012, 36(4):1342-1356.
38. Spitzer R.L., Gibbon M., Endicott J. Global Assessment Scale (GAS), Global Assessment of Functioning (GAF) scale, Social and Occupational Functioning Assessment Scale (SOFAS). Handbook of Psychiatric Measures 2000, American Psychiatric Association, Washington. A.J. Rush (Ed.).
39. Spitzer R., Williams J., Gibbon M. Structured Clinical Interview for DSM-III-R-Patient Edition 1989, Biometrics Research Department New York State Psychiatric Institute.
40. Staal W.G., Hulshoff Pol H.E., Schnack H.G., van Haren N.E., Seifert N., Kahn R.S. Structural brain abnormalities in chronic schizophrenia at the extremes of the outcome spectrum. Am J Psychiatry 2001, 158(7):1140-1142.
41. Steen R.G., Mull C., McClure R., Hamer R.M., Lieberman J.A. Brain volume in first-episode schizophrenia: systematic review and meta-analysis of magnetic resonance imaging studies. Br J Psychiatry 2006, 188:510-518.
42. Suckling J., Brammer M.J., Lingford-Hughes A., Bullmore E.T. Removal of extracerebral tissues in dual-echo magnetic resonance images via linear scale-space features. Magn Reson Imaging 1999, 17(2):247-256.
43. Suckling J., Sigmundsson T., Greenwood K., Bullmore E.T. A modified fuzzy clustering algorithm for operator independent brain tissue classification of dual echo MR images. Magn Reson Imaging 1999, 17(7):1065-1076.
44. Tanskanen P., Ridler K., Murray G.K., Haapea M., Veijola J.M., Jaaskelainen E., et al. Morphometric brain abnormalities in schizophrenia in a population-based sample: relationship to duration of illness. Schizophr Bull 2010, 36(4):766-777.
45. Tanskanen P., Veijola J.M., Piippo U.K., Haapea M., Miettunen J.A., Pyhtinen J., et al. Hippocampus and amygdala volumes in schizophrenia and other psychoses in the Northern Finland 1966 birth cohort. Schizophr Res 2005, 75(2-3):283-294.
46. Tzourio-Mazoyer N., Landeau B., Papathanassiou D., Crivello F., Etard O., Delcroix N., et al. Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage 2002, 15(1):273-289.
47. van Haren N.E., Cahn W., Hulshoff Pol H.E., Schnack H.G., Caspers E., Lemstra A., et al. Brain volumes as predictor of outcome in recent-onset schizophrenia: A multi-center MRI study. Schizophr Res 2003, 64(1):41-52.
48. Vita A., De Peri L., Deste G., Sacchetti E. Progressive loss of cortical grey matter in schizophrenia: a meta-analysis and meta-regression of longitudinal MRI studies. Transl Psychiatry 2012, 2:e190. 10.1038/tp.2012.116.
49. Wilke M., Kaufmann C., Grabner A., Pütz B., Wetter T.C., Auer D.P. Grey matter-changes and correlates of disease severity in schizophrenia: a statistical parametric mapping study. Neuroimage 2001, 13(5):814-824.